Nrf2 may play a pivotal role in the development of NASH, because it represses the expression of genes involved in FA synthesis (29, –, 31) and antagonizes inflammation (32). This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.